From the ∗Department of Medicine, University Miguel Hernandez, Elche
†Instituto de InvestigaciĂ³n Sanitaria y BiomĂ©dica de Alicante (ISABIAL)
‡Department of Rheumatology; Hospital General Universitario de Alicante, Alicante
§Department of Rheumatology; Hospital General Universitario de Elda, Elda, Spain.
This study had no external funding source. E.P. declares no conflict of interest. M.A. has received speaking and advisory fees from Menarini, AstraZeneca, GrĂ¼nenthal, and Horizon. F.S. has received speaking and advisory fees from Menarini, AstraZeneca, GrĂ¼nenthal, and Horizon.
All authors contributed to the drafting of the manuscript and approved the final version.
Correspondence: Eliseo Pascual, MD, PhD, Universidad Miguel Hernandez. Carretera Nacional 332 s/n, 03550, San Juan de Alicante, Alicante, Spain. E-mail: [email protected].
